James Harrison

James is the founder and Executive Chairman of Cycle Pharmaceuticals, a young Cambridge-based company focused on improving existing pharmaceuticals. James was formerly CEO of Archimica, an international contract manufacturing organization of active pharmaceutical ingredients and their pre-cursors for the global branded and generic pharmaceutical industries. Archimica has manufacturing sites in the US, UK, Germany, France, and Italy. During his tenure at Archimica, James recruited and led a new management team, and implemented a detailed strategic repositioning of the business. Archimica was sold to the Euticals group in 2011. Prior to Archimica, James was a Managing Director at TowerBrook Capital Partners and a Partner at Soros Private Equity Partners. James began his career working in the mergers and acquisitions department of Morgan Stanley. James holds a first-class MA and MPhil degrees from the University of Cambridge.